Clinic
Saint Anthony Hospital
Saint Anthony Hospital was paid $4.39M by Medicaid between Jan 2018 and Feb 2024, across 128 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 65% of everything it billed.
33Billing provider infoSAINT ANTHONY HOSPITAL
CHICAGO, IL 60623
CHICAGO, IL 60623
33aNPI1194723999assigned 07/14/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$4.39M
24GClaims138,337
24DCodes billed128
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Illinois
Rank by total paid#7 of 28
Median peer was paid$388K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,012 | $1.23M | |
| 2019 | 78,140 | $2.35M | |
| 2020 | 21,004 | $813K | |
| 2024incomplete | 181 | $314.19 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 65% | 28,147 | 7,195 | $2.84M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7.2% | 17,418 | 3,890 | $315K |
| 97161 | 6.5% | 2,607 | 2,243 | $286K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.7% | 2,430 | 1,086 | $118K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.6% | 2,732 | 1,133 | $72K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 2,638 | 971 | $57K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 940 | 895 | $54K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.1% | 1,250 | 160 | $47K |
| 0502F | <1% | 949 | 175 | $40K | |
| 97162 | <1% | 291 | 254 | $32K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 701 | 333 | $31K |
| 97010 | <1% | 1,056 | 434 | $27K |
116 more codes
| 92557 | <1% | 706 | $25K | |
| 29075 | <1% | 399 | $21K | |
| 29405 | <1% | 357 | $19K | |
| 90733 | <1% | 324 | $18K | |
| 73610 | <1% | 1,393 | $17K | |
| 92567 | <1% | 1,132 | $17K | |
| 29700 | <1% | 881 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,393 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 408 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,396 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 653 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,377 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,160 | $12K |
| 73630 | <1% | 1,241 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,452 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 2,938 | $10K |
| 72081 | <1% | 718 | $10K | |
| 73110 | <1% | 1,177 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,280 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,255 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 257 | $8K |
| 73562 | <1% | 871 | $8K | |
| 90716 | <1% | 583 | $8K | |
| 90715 | <1% | 694 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 71 | $7K |
| 83655 | <1% | 1,483 | $7K | |
| 29085 | <1% | 174 | $7K | |
| 72170 | <1% | 1,495 | $7K | |
| 90670 | <1% | 1,483 | $6K | |
| 73130 | <1% | 847 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 588 | $6K |
| 90686 | <1% | 849 | $6K | |
| 97165 | <1% | 435 | $5K | |
| 87481 | <1% | 393 | $4K | |
| 87088 | <1% | 1,450 | $4K | |
| 73565 | <1% | 246 | $4K | |
| 90633 | <1% | 607 | $4K | |
| 73030 | <1% | 361 | $4K | |
| 73080 | <1% | 458 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,407 | $3K |
| 92523 | <1% | 165 | $3K | |
| 86480 | <1% | 155 | $3K | |
| 90698 | <1% | 412 | $3K | |
| 90656 | <1% | 501 | $3K | |
| 72100 | <1% | 210 | $3K | |
| 90707 | <1% | 385 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,708 | $3K |
| 80061 | Lipid panel | <1% | 1,766 | $2K |
| 84439 | <1% | 1,043 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 174 | $2K |
| 80050 | General health panel | <1% | 717 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 424 | $2K |
| 90651 | <1% | 381 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,913 | $2K |
| 87590 | <1% | 206 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 298 | $2K |
| 29065 | <1% | 33 | $1K | |
| 72072 | <1% | 260 | $1K | |
| 86003 | <1% | 115 | $1K | |
| 87490 | <1% | 206 | $1K | |
| 90658 | <1% | 168 | $1K | |
| 85018 | <1% | 2,825 | $1K | |
| 85014 | <1% | 2,727 | $1K | |
| 84480 | <1% | 372 | $1K | |
| 90648 | <1% | 295 | $1K | |
| 73140 | <1% | 174 | $1K | |
| 81001 | <1% | 1,591 | $1K | |
| 94760 | <1% | 570 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 525 | $1K |
| 73590 | <1% | 119 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 158 | $914.63 |
| 84703 | <1% | 405 | $813.44 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 229 | $724.96 |
| 85610 | <1% | 473 | $585.84 | |
| 72110 | <1% | 30 | $558.30 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 61 | $445.01 |
| 81003 | <1% | 904 | $437.33 | |
| 82728 | <1% | 196 | $424.22 | |
| 90696 | <1% | 75 | $396.28 | |
| 73502 | <1% | 19 | $377.96 | |
| 82248 | <1% | 368 | $374.08 | |
| Q3014 | Telehealth originating site facility fee | <1% | 15 | $371.40 |
| 87070 | <1% | 227 | $370.90 | |
| 82378 | <1% | 44 | $350.47 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 119 | $308.32 |
| 74018 | <1% | 32 | $299.82 | |
| 82570 | <1% | 288 | $283.16 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $281.55 |
| 90461 | <1% | 1,928 | $276.43 | |
| 86256 | <1% | 76 | $265.32 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 239 | $252.00 |
| 86592 | <1% | 340 | $251.12 | |
| 87186 | <1% | 93 | $245.19 | |
| 84153 | <1% | 45 | $244.32 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 73 | $164.43 |
| 86606 | <1% | 81 | $161.52 | |
| 82947 | <1% | 167 | $146.77 | |
| 90681 | <1% | 76 | $145.89 | |
| 82785 | <1% | 100 | $131.26 | |
| 86580 | <1% | 43 | $130.88 | |
| 72040 | <1% | 13 | $118.16 | |
| 90700 | <1% | 61 | $113.90 | |
| 81025 | <1% | 150 | $93.40 | |
| 82043 | <1% | 123 | $91.61 | |
| 83001 | <1% | 12 | $80.81 | |
| 82962 | <1% | 88 | $65.59 | |
| 86850 | <1% | 43 | $52.74 | |
| 82247 | <1% | 55 | $43.49 | |
| 81002 | <1% | 76 | $42.75 | |
| 86901 | <1% | 43 | $30.30 | |
| 90657 | <1% | 32 | $25.26 | |
| 84156 | <1% | 47 | $20.31 | |
| 86900 | <1% | 42 | $17.42 | |
| 90685 | <1% | 34 | $6.31 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 54 | $3.41 |
| A9270 | Non-covered item or service | 0% | 556 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANOSIKE, DENNIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Saint Anthony Hospital | Chicago, IL | $326.99 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.